276 related articles for article (PubMed ID: 24074191)
21. Screening for attention-deficit/hyperactivity disorder in adult inpatients with psychiatric disorders.
Kumar G; Faden J; Steer RA
Psychol Rep; 2011 Jun; 108(3):815-24. PubMed ID: 21879629
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study.
Park S; Cho MJ; Chang SM; Jeon HJ; Cho SJ; Kim BS; Bae JN; Wang HR; Ahn JH; Hong JP
Psychiatry Res; 2011 Apr; 186(2-3):378-83. PubMed ID: 20724004
[TBL] [Abstract][Full Text] [Related]
23. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
Paslakis G; Schredl M; Alm B; Sobanski E
Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520
[TBL] [Abstract][Full Text] [Related]
24. An exploratory clinical study of adult attention deficit/hyperactivity disorder from India.
Sitholey P; Agarwal V; Sharma S
Indian J Med Res; 2009 Jan; 129(1):83-8. PubMed ID: 19287063
[TBL] [Abstract][Full Text] [Related]
25. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
Regan T; Tubman J
Subst Use Misuse; 2020; 55(1):119-132. PubMed ID: 31502500
[No Abstract] [Full Text] [Related]
26. Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study.
Connor DF; Ford JD
J Clin Psychiatry; 2012 May; 73(5):711-7. PubMed ID: 22697195
[TBL] [Abstract][Full Text] [Related]
27. Attention-Deficit Hyperactivity Disorder Symptom Status in a Mixed Gender Population of Opioid-Maintained Prison Inmates.
Silbernagl M; Slamanig R; Stegemann M; Sterzer M; Mayer L; Fischer G; Unger A
Eur Addict Res; 2019; 25(2):80-92. PubMed ID: 30783059
[TBL] [Abstract][Full Text] [Related]
28. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
[TBL] [Abstract][Full Text] [Related]
29. Drug preferences in illicit drug abusers with a childhood tendency of attention deficit/hyperactivity disorder: a study using the Wender Utah Rating Scale in a Japanese prison.
Matsumoto T; Yamaguchi A; Asami T; Kamijo A; Iseki E; Hirayasu Y; Wada K
Psychiatry Clin Neurosci; 2005 Jun; 59(3):311-8. PubMed ID: 15896225
[TBL] [Abstract][Full Text] [Related]
30. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients.
Halmøy A; Fasmer OB; Gillberg C; Haavik J
J Atten Disord; 2009 Sep; 13(2):175-87. PubMed ID: 19372500
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
Levin FR
J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
[TBL] [Abstract][Full Text] [Related]
32. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
Fatseas M; Debrabant R; Auriacombe M
Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
[TBL] [Abstract][Full Text] [Related]
33. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
[TBL] [Abstract][Full Text] [Related]
34. Attention deficit hyperactivity disorder in men and women newly committed to prison: clinical characteristics, psychiatric comorbidity, and quality of life.
Westmoreland P; Gunter T; Loveless P; Allen J; Sieleni B; Black DW
Int J Offender Ther Comp Criminol; 2010 Jun; 54(3):361-77. PubMed ID: 19270267
[TBL] [Abstract][Full Text] [Related]
35. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.
Martinez-Raga J; Szerman N; Knecht C; de Alvaro R
Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
Biederman J
J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
[TBL] [Abstract][Full Text] [Related]
37. Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor?
Kousha M; Shahrivar Z; Alaghband-Rad J
J Atten Disord; 2012 May; 16(4):325-32. PubMed ID: 22127397
[TBL] [Abstract][Full Text] [Related]
38. [Drug addiction in young prison inmates with and without attention deficit hyperactivity disorder (ADHD)].
Retz W; Retz-Junginger P; Schneider M; Scherk H; Hengesch G; Rösler M
Fortschr Neurol Psychiatr; 2007 May; 75(5):285-92. PubMed ID: 16586260
[TBL] [Abstract][Full Text] [Related]
39. Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history.
Murphy KR; Barkley RA; Bush T
J Nerv Ment Dis; 2002 Mar; 190(3):147-57. PubMed ID: 11923649
[TBL] [Abstract][Full Text] [Related]
40. Comorbid psychiatric disorders in a clinical sample of adults with ADHD, and associations with education, work and social characteristics: a cross-sectional study.
Anker E; Bendiksen B; Heir T
BMJ Open; 2018 Mar; 8(3):e019700. PubMed ID: 29500213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
